General Information of the Compound
| Compound ID |
CP0466743
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N,N′-(10-oxo-3,6,14,17-tetraoxa-9,11-diazanonadecane-1,19-diyl)bis(4-(6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinolin-4-yl)benzenesulfonamide)
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C45H56Cl4N6O9S2
|
||||||||||||||||||
| Molecular Weight |
1030.922
|
||||||||||||||||||
| Canonical SMILES |
CN1CC(c2ccc(cc2)S(=O)(=O)NCCOCCOCCNC(=O)NCCOCCOCCNS(=O)(=O)c2ccc(cc2)C2CN(C)Cc3c(Cl)cc(Cl)cc23)c2cc(Cl)cc(Cl)c2C1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C45H56Cl4N6O9S2/c1-54-27-39(37-23-33(46)25-43(48)41(37)29-54)31-3-7-35(8-4-31)65(57,58)52-13-17-63-21-19-61-15-11-50-45(56)51-12-16-62-20-22-64-18-14-53-66(59,60)36-9-5-32(6-10-36)40-28-55(2)30-42-38(40)24-34(47)26-44(42)49/h3-10,23-26,39-40,52-53H,11-22,27-30H2,1-2H3,(H2,50,51,56)
Show/Hide
|
||||||||||||||||||
| InChIKey |
SXPBNCPKICHUFU-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04309, Sodium/hydrogen exchanger 3
Protein ID: PT03762, Sodium/hydrogen exchanger 3